S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.

Different Methods of Obtaining Cheap Medication Via Pharmacy Reviews

People all over the world demand numerous medication for everyday needs. For the different prescription drugs needed, there are ways, like visiting pharmacy reviews, for people to get them a great deal more affordable through online sources.Daily drugs are becoming more and more difficult for people to handle the expenses of these days. With the constant increase in the costs of all things currently, folks are likewise going through an increase in the difficulty of managing such expenditures. People everywhere are seeking different means and choices to getting cheaper medication with the continuous increase of prices just about everywhere. There are a variety of ways for people to get cheaper and safer medication today. People should make use of all these solutions to really take advantage of their funds and save a significant sum of money they can use for other pursuits.Buying medication from online pharmacies is certainly one way for families all over the globe to save cash on medical expenses. Online pharmacies sell medication at significantly cheaper prices compared to regular pharmacies. This is mainly because online pharmacies usually do not require the normal upkeep and staffing required in operating a regular pharmacy, and will therefore charge less for any goods that they sell.You will need to note, however, that not all online pharmacies can be trusted. There are several internet sites that pretend to be legitimate, but are in reality fraudulent websites intent on scamming people out of their money. People should find ways to verify if a site is legitimate or not before buying anything. One sure way of doing this is by reading through online pharmacy review internet sites.Online pharmacy review sites can be considered sources for people to get cheaper medication. Given that buying medication from online pharmacies are a lot cheaper than buying from regular pharmacies, making sure to check on pharmacy reviews is a must. Online pharmacy review sites can provide information not only regarding the most reliable sites to buy from, but also where the cheapest forms of prescription drugs can be found. This is why a lot of people really should consider first looking through many different pharmacy review sites.People could make use of pharmacy review sites diversely. Besides simply searching for the lowest priced distributor of specific prescription drugs, those who are searching for more affordable medication may also look for generic drugs. Generic medication is probably the lowest priced form that one will find prescription medicine in, and is particularly for sale in many online drug stores. Some pharmacies even carry only generic products. Online customers can search for generic-pharmacy review sites, which are more specifically suited to those thinking about generic medication. There are numerous generic-pharmacy review web sites available on the internet today, providing enough detailed information online about internet vendors that sell generic medication. Via such product-specific sites, people will find their least expensive yet secure sources for generic medicine.There are plenty of different ways to save cash when purchasing necessary medication. These guidelines however, can make sure that you can get some savings each and every time you buy prescription drugs. Reviewing an online pharmacy review site is one of the best ways you will find out where one can buy medication safely and effortlessly.

Sharing The Good News

Have you ever felt like you just had to share your latest good news with anyone and everyone around you, but they literally had no interest whatsoever in what you had to say? Although intended for the best, sometimes sharing the good news is not always a positive outcome.After all, people know you remember things.And every time they see you coming with that “have I got a deal for you” look of wide eyed innocence about you… they also know to be very aware with the question in their minds… what is he going to try and sell on now!?More often than not it seems as if you’re the only one oblivious to their burn out of your good news tactics and gracious offers for them to improve their lives and make more money and retire to the Florida Keys sooner than later while improving their health and well being with your new vita-pill-drink!.Both they and you know that you’re really not a bad person. The fact of the matter is that you just want to see everyone as healthy and happy as your latest new venture is promising to make the both of you. You’re just sharing the good news. I mean, after all, you could see and realize the benefits of this amazing product and were immediately sold on it… so everyone you know should jump on this opportunity as sure and as fast as you did, right!You don’t need that kind of pressure. Time to get this monkey off you back!So, as a new business person, you have to write these folks off your list and warm and friendly contacts (because the industry of network marketing labels them that way) and you end up losing your rank and status in the arena of family and friends because that same win at all costs industry says if they cannot or will not support you in whatever your dreams are, then you didn’t need them anyway.So, does that mean the pressure is now off and you as a big shot entrepreneur are free and able to tackle anyone you come in contact with using your new found attitude as fair game for your business? I would certainly hope not. That is a pure case of not sharing the good news!What you really need to remember at this point in your little business rant to save the world is… “don’t try to share your seemingly good fortune” with everyone or everything that moves!Keep in mind that some people will be wide open to change and new ideas, having been prepared by the your giving spirit from times past.But, there are those that you have engaged just as soberly before that may not be so open to yet another invitation to be set free from your definition of their less than stellar lives.When you come across those that are not, relax, don’t push them. When it comes to sharing the good news, you need to realize that it’s just not their time.If and when you sense a resistance or an uncomfortable response, just tactfully, professionally and lovingly change the subject.Demonstrate true sensitivity and concern for this person and be mindful that their time will come..it may be next week, next month or perhaps even tomorrow..or even more so, never. You just need to stay close to your moral and ethical business conventions. There’s a time and a place for everything and everyone.Having said that, I have to also state that I am not putting down or am opposed to the great many men and women who make their livelihoods persuading and selling to the masses in our society. Some of these great selling giants do come with even greater values in sharing the good news.Giving in is not necessarily always a matter of giving up.Sometimes you have to give yourself permissions to leave, to walk away, to not challenge certain conventions. And in doing so, you will gain a healthy respect for the individual as you are encouraged to listen to your inner-self and be a guiding force rather than just another selling force for something that many may not be in the market to buy.A Friend in Business… and Life… Always,-Lon-